Brege Laura
SEC-identified person · CIK 1365619 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Director | filed 2021 - 2026 |
| Mirum Pharmaceuticals, Inc. MIRM | Director | filed 2019 - 2026 |
| Pacira Pharmaceuticals, Inc. PCRX | Director | filed 2011 - 2026 |
| Acadia Pharmaceuticals INC ACAD | Director | filed 2008 - 2026 |
| Portola Pharmaceuticals INC PTLA | Director | filed 2015 - 2020 |
| Dynavax Technologies Corp dvax | Director | filed 2015 - 2019 |
| Aratana Therapeutics, INC. PETX | Director | filed 2014 - 2018 |
| Delcath Systems, INC. DTCH | Director | filed 2012 - 2014 |
| Onyx Pharmaceuticals INC ONXX | EVP, Corporate Affairs | filed 2006 - 2011 |
| Angiotech Pharmaceuticals INC ANPMF | Director | filed 2008 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.